Literature DB >> 35759475

Knowledge, attitude, and hesitancy towards COVID-19 vaccine among university students of Bangladesh.

Md Mostafizur Rahman1, Musabber Ali Chisty2, Md Ashraful Alam3, Mohammed Sadman Sakib1, Masrur Abdul Quader1, Ifta Alam Shobuj1, Md Abdul Halim1, Farzana Rahman4.   

Abstract

Global vaccination coverage is an urgent need to recover the recent pandemic COVID-19. However, people are concerned about the safety and efficacy of this vaccination program. Thus, it has become crucial to examine the knowledge, attitude, and hesitancy towards the vaccine. An online cross-sectional survey was conducted among university students of Bangladesh. Total of 449 university students participated. Most of these students used the internet (34.74%), social media (33.41%), and electronic media (25.61%) as a source of COVID-19 vaccine information. Overall, 58.13% and 64.81% of university students reported positive knowledge and attitude towards the COVID-19 vaccine. 54.34% of these students agreed that the COVID-19 vaccine is safe and effective. 43.88% believed that the vaccine could stop the pandemic. The Spearman's Rank correlation determined the positive correlation between knowledge and attitude. The negative correlation was determined between positive knowledge and hesitancy, and positive attitude and hesitancy. University students with positive knowledge and attitude showed lower hesitancy. Multiple logistic regression analyses determined the university type and degree major as the predictors of knowledge, whereas only degree major was the predictor of attitudes. 26.06% of the study population showed their hesitancy towards the vaccine. University type and degree major were also determined as predictors of this hesitancy. They rated fear of side effects (87.18%) and lack of information (70.94%) as the most reasons for the hesitancy. The findings from this study can aid the ongoing and future COVID-19 vaccination plan for university students. The national and international authorities can have substantial information for a successful inoculation campaign.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35759475      PMCID: PMC9236250          DOI: 10.1371/journal.pone.0270684

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

The World Health Organization declared COVID-19 as a pandemic on March 11, 2020 [1]. Over 200 countries have already been affected by the pandemic [2]. This highly contagious disease has become a burden for the world. Millions of COVID-19 cases and deaths [3] have made the situation uncertain. Global communities continue to battle the public health crises arising from the long-term pandemic. It has also triggered formidable socio-economic and psychological impacts [4]. A safe and effective COVID-19 vaccine has become urgent for every region. Many countries have already started the inoculation campaign for their people [5]. Millions of COVID-19 vaccines have already been administered to stop the pandemic [3]. Several vaccines have already been available to rollout globally [6]. However, a successful inoculation campaign requires enough knowledge and positive attitudes towards the vaccine. A lack of knowledge and attitude may create vaccine hesitancy, defined as “the decision to delay vaccination or the refusal to vaccinate despite available vaccination services” [7]. In the past, vaccine hesitancy has been observed against influenza, human papillomavirus, and pneumococcal vaccines [8-11]. The hesitancy was also found for COVID-19 vaccines in some countries [12-15]. Numerous studies conducted in the Czech Republic, Italy, Lebanon, and Bangladesh revealed that a variety of socio-demographic factors, behavioral patterns, vaccine availability, side effects, a lack of information, or a lack of trust regarding the COVID-19 vaccine might all contribute to the hesitancy [13, 16–19]. COVID-19 vaccine rejection was found to be much higher among the elderly, rural, semi-urban, and slum groups, farmers, day laborers, and homemakers, as well as those with low education and lack of confidence in Bangladesh’s healthcare system [20]. The skyrocketing COVID-19 cases in India and Nepal [3] has placed the situation worst in the South-Asian region. As a neighboring country, Bangladesh has also struggled to control the pandemic by applying the lockdown process [21]. Bangladesh’s government began providing Covidshield, an Oxford AstraZeneca vaccine, to the general population, and additional vaccines including Moderna, Pfizer, and SinoPharma have also been launched [19, 22]. As of December 8, 2021, 7 vaccines were approved for use in Bangladesh [23]. However, as is the case in many other countries, the government initially focused vaccination efforts on relatively limited categories of people (frontline medical personnel, government employees, private sector officials working on pandemic issues, and people aged 40 years and over), with the anticipation that the entire population would be eligible for vaccinations later [19, 24]. On February 7, 2021, the authority launched a mass COVID-19 vaccination campaign [25]. 106,575,146 vaccines have already been administered, with 24.32% (39,653,764) of the entire population completely vaccinated as of December 8, 2021 [26]. Initially, the authority did not include university students. However, all the universities were closed from the public holidays [27] initiated to control the pandemic. These educational institutes have suffered a lot due to the pandemic [28]. Several strategies, such as online classes and planning to open the institutes maintaining the health behavior, have already been taken to continue the higher education. However, all these strategies faced severe challenges and, in some cases, failed [29]. Therefore, the authority has decided to open the university after an inoculation campaign for university students [30]. However, people are concerned about the safety and efficacy of this vaccination program [31]. Hence, it should be noteworthy that the growing concerns over the vaccine’s safety and efficacy may delay this vaccination process. Universities in Bangladesh have reopened in October, 2021 [32]. Nonetheless, all of these students must be vaccinated against COVID-19. A study is necessary to determine these students’ knowledge, attitude, and hesitancy (KAH) concerning COVID-19 vaccinations. Apart from the significance of this study, there was a dearth of research on university students, with the exception of a few studies on the general population of Bangladesh [18-20]. The main objective of this study is to evaluate the KAH level towards the COVID-19 vaccine among university students of Bangladesh. The research questions for this study are “What are the knowledge and attitude levels regarding COVID-19 vaccine among these students?”, “What are the socio-demographic and academic factors associated with the KAH level of university students towards the COVID-19 vaccine?”, and “Which factors could lead these students towards hesitancy regarding the COVID-19 vaccination?”.

Materials and methods

Research design

The current survey was performed among university students of Bangladesh. They were also divided into five categories based on their majors: Arts and Social Science (an interdisciplinary field of study that encompasses behavioral and social science), Business and Economics (which focuses on business analysis, microeconomics, macroeconomics, financial and management information, and so on), Science and Engineering (which includes students who study diverse subjects such as biological science, physics, chemistry, and other engineering subjects), and Science and Engineering (which includes students who study diverse subjects such as natural science, physics, chemistry, etc.), and Medical Studies. This cross-sectional study examined the KAH level towards the newly administered COVID-19 vaccine. Due to the ongoing pandemic, a rapid online self-reported KAH survey was carried out. The boundary conditions were university students living in Bangladesh and required internet access. We followed The Checklist for Reporting Results of Internet Surveys (CHERRIES) guidelines [33]. This study was approved by the Ethical Review Committee of the Institute of Disaster Management and Vulnerability Studies, University of Dhaka, Bangladesh (ERC-01/020221). It has maintained all the ethical issues. Consents over the phone and through online conversations were taken from the participants. The cover page of the questionnaire also clearly described the length of time of the survey, confidentiality of the data, the purpose of the study, the research team, and associated ethical issues. There was no incentive for the participants. Respondents were entirely free to leave the online survey at any point.

Survey tools

Literature reviews regarding the COVID-19 vaccine [24, 34–36] were performed. A draft electronic questionnaire, both in English and translated local Bengali version, was then prepared in Google form. A pilot survey conducted among some university students, experts’ opinions, and cultural appropriateness were considered for preparing the final electronic questionnaire. The final questionnaire had five sections with mandatory response items, such as socio-demographic and academic information of the university students; most used sources for COVID-19 vaccine-related information and if they tested COVID-19 positive before; knowledge section; attitude section; and hesitancy section. The hesitancy section was only for the respondents who reported their hesitancy. Total 20 items were in the KAH section (knowledge = 09, attitude = 05 and hesitancy = 06 items). A same scale range of 0–1 was designed for all the items (positive response and hesitancy = 1, neutral response = 0.5 and negative response/don’t know/disagree/no hesitancy = 0). The knowledge section had the statements regarding the vaccine’s effectiveness, health behavior after 1st dose of the vaccine, side effects, and misconceptions about the vaccine (Table 3). The attitude section contained the pandemic concerns, vaccine safety and effectiveness, and willingness to pursue the vaccine (Table 4). The hesitancy section contained the reasons for hesitancy towards the vaccine. This section addressed the perception of ineligibility to pursue the vaccine, lack of enough information, fear of side effects, the probable cost of the vaccine, religious views, and other reasons (Table 8). We also calculated the Cronbach’s Alpha as 0.86, 0.83, and around 0.60 for the knowledge, attitude, and hesitancy section, respectively. 0.60–0.70 are generally accepted values for internal consistency, where greater than 0.80 determines the excellent level [37, 38].
Table 3

Knowledge towards COVID-19 vaccination (n = 449).

StatementsPositive Responses
n (%)95% CIa
COVID-19 vaccine is effective against the infection256 (57.02)53.4–61.6
Health behaviour is required to follow even after vaccination395 (87.97)84.9–90.9
Vaccinated can help from serious illness due to the COVID-19309 (68.82)64.5–73.1
Full vaccination may help to do normal activities313 (69.71)65.4–73.9
Bangladeshi can register for COVID-19 vaccination through a website375 (83.52)80.0–86.9
COVID-19 vaccine may have some side effects like other vaccines394 (87.75)84.7–90.7
If there is any side effect due to the COVID-19 vaccination, they normally go in a few days325 (72.38)68.2–76.5
COVID-19 vaccine can cause infertility264 (58.80)60.4–69.2
COVID-19 vaccine can cause long-term physical problems248 (55.23)59.2–68.2

aCI = Confidence Intervals.

Table 4

Attitude towards COVID-19 vaccination (n = 449).

StatementsPositive Attitudes
n (%)95% CIa
Concerned about the COVID-19385 (85.75)82.5–88.9
COVID-19 vaccine is safe and effective244 (54.34)49.7–58.9
I need to take the vaccine as soon as possible if I am eligible295 (65.70)61.3–70.1
I should aware and motivate my family members and neighbours to take the vaccine289 (64.37)59.9–68.8
COVID-19 vaccination will help us to stop the pandemic197 (43.88)39.3–48.5

aCI = Confidence Intervals.

Table 8

Reasons of hesitancy towards COVID-19 vaccine (n = 117).

StatementsHesitated
n (%))95% CI
Fear of ineligibility46 (39.32)30.3–48.3
Lack of information83 (70.94)62.6–79.3
Fear of side effects102 (87.18)81.0–93.3
Probable cost of vaccination07 (5.98)1.6–10.3
Against religious beliefs03 (2.56)-0.3–5.4
Other reasons53 (45.30)36.1–54.4

aCI = Confidence Intervals.

Data collection and data analysis

A group of university students was recruited (based on their research experience) to administer the questionnaire from March 12 to April 02, 2021. Several online platforms, namely Facebook, email, WhatsApp, Imo, and Google classroom, were used. We followed the convenience sampling technique. Convenience sampling is a technique for non-probabilistic sampling that is frequently used in clinical research. Typically, this sampling strategy draws clinical cases or participants from an easily accessible area, such as a medical records database, an internet site, or a customer membership list [39]. Morgan’s Table [40] determined the minimum required respondents were 384 for this perception-based study (95% Confidence Interval (CI)). A total of 462 university students participated (completed the questionnaire) in the survey, where approximately 500 students were approached. Thus 92.40% was the overall participation rate for this study. However, we only considered 449 unvaccinated university students in the final analysis. To maintain the ethical issue of participant anonymity, we did not use cookies or the IP addresses of the participants’ devices. Nevertheless, the study team monitored and double-checked the data on a frequent basis in order to avoid biases. Data management and statistical analyses were performed by using Python (version 2.7; Beaverton, OR 97008, USA) and RStudio (version 1.2.5042; Boston, MA, USA) [41, 42]. Descriptive statistics such as the frequency and percentages were calculated where appropriate. Total knowledge and attitude scores were calculated by summing of respective item scores. A positive level in the knowledge and attitude section was determined based on the 80% cut-off scores [43]. For example, 7.2 was calculated as 80% score in the knowledge section. Thus, 7 and more than that was considered as positive knowledge level. Positive level/hesitancy and negative level/no hesitancy were scored 1 and 0, respectively. The Spearman’s Rank correlation was carried out to determine the correlation in the KAH domain. Univariate and multiple logistic regression analyses were also performed to determine the predictors of knowledge, attitude, and hesitancy.

Results

Table 1 summarizes the socio-demographic and academic information of the participants. This study had about an equal proportion of male (51.67%) and female (48.33%) participants. The majority of the students were unmarried (93.10%), living with their family (90.42%), living in Dhaka city (73.94%). 63.70% were from government-funded public universities. 21.60% of the participants tested COVID-19 positive before.
Table 1

Socio-demographic and academic information (n = 449).

Features n %
1. Gender
• Male23251.67
• Female21748.33
2. Marital status
• Married316.90
• Unmarried41893.10
3. Living with family
• Yes40690.42
• No439.58
4. Current accommodation
• Dhaka city33273.94
• Outside Dhaka city11726.06
5. University type
• Public28663.70
• Private16336.30
6. University year
• 1st and 2nd year11726.06
• 3rd year20044.54
• 4th year and Masters13229.40
7. Degree Major
• Arts and Social Science12126.95
• Business and Economics6915.37
• Science and Engineering14131.40
• Security and Strategic Studies5712.69
• Medical Studies6113.59
8. COVID-19 positive before
• Yes9721.60
• No35278.40
Table 2 demonstrates that university students used the internet (34.74%), social media (33.41%), and electronic media (25.61%) for COVID-19 vaccine-related information. The internet is a massive network that links devices (such as computers and smartphones) located worldwide. Individuals may exchange information and converse through the internet from any location with an internet connection. We defined social media as electronic modes of communication in which users build online communities to exchange information, ideas, personal messages, and other material. They are the foundations for the interactive web. They accomplish this by encouraging users to engage in, comment on, and create content. For example, Facebook. Electronic media is any form of media that can be shared on any electronic device for the purpose of viewing by an audience; unlike static media (printing), electronic media is transmitted to a larger audience. Electronic media include television (TV) and radio.
Table 2

Most used sources of COVID-19 related information.

Sources of COVID-19 related informationn (%)
Internet156 (34.74)
Social media150 (33.41)
Electronic media (TV, Radio)115 (25.61)
University18 (4.01)
People (community, family members)6 (1.30)
Print media4 (0.87)
Table 3 presents the positive responses regarding the health behavior even after the vaccination (87.97%), a website for vaccine registration in Bangladesh (83.52%), side effects due to the vaccination (87.75%), and these side effects normally go in a few days (72.38%). 57.02% of respondents also reported that the COVID-19 vaccine is effective against the disease, and 68.82% believed that vaccination could help from severe illness due to the COVID-19. 69.71% of individuals thought that the full vaccination might help do everyday activities. 58.80% and 55.23% of the participants positively replied that infertility and long-term physical problems due to the COVID-19 vaccine are misconceptions. aCI = Confidence Intervals. 85.75% of participants were concerned about the pandemic, whereas 54.34% agreed on the safety and efficacy of the vaccine (Table 4). About 65% of individuals agreed that they and their family members should take the vaccine. However, less than 50% (43.88%) of the university students agreed that the COVID-19 vaccination could stop the ongoing pandemic. aCI = Confidence Intervals. Table 5 shows the association in the KAH domain. Knowledge and attitude had positive correlation (r = 0.452), whereas knowledge (r = -0.453) and attitude (r = -0.338) both were negatively correlated with the hesitancy. Increased odds of having a positive attitude (OR: 7.60; 95% CI: 4.94–11.85) were found for positive knowledge. Decreased odds of having hesitancy were recorded for the students with positive knowledge (OR: 0.10; 95% CI: 0.06–0.17) and a positive attitude (OR: 0.20; 95% CI: 0.13–0.32).
Table 5

Association in knowledge, attitude, and hesitancy domain towards COVID-19 vaccine (n = 449).

Associationr-valuebORc (95% CI)
Knowledge vs Attitude0.452***Positive Knowledge 7.60 (4.94–11.85) ***
Knowledge vs Hesitancy-0.453***Positive Knowledge 0.10 (0.06–0.17) ***
Attitude vs Hesitancy-0.338***Positive Attitude 0.20 (0.13–0.32) ***

*p<0.05

**p<0.01

***p<0.001.

br-value = correlation coefficient.

cOR = Odds Ratio.

*p<0.05 **p<0.01 ***p<0.001. br-value = correlation coefficient. cOR = Odds Ratio. Overall, 58.13% and 64.81% of university students reported positive knowledge and attitude towards the COVID-19 vaccine. Table 6 summarizes the univariate and multiple logistic regression analysis results for knowledge and attitude level. University type and degree major were determined as significant predictors of knowledge level. Public university students reported decreased odds of having positive knowledge (OR: 0.19; 95% CI: 0.12–0.30) than private university students. Conversely, increased odds of having a positive knowledge were found among the students majoring in Business and Economics (OR: 2.39; 95% CI: 1.31–4.41), Science and Engineering (OR: 5.69; 95% CI: 3.36–8.81), and Medical studies (OR: 27.80; 95% CI: 10.52–96.45) compared to the students from Arts and Social Science. All the significant predictors in univariate analyses remained significant in multiple logistic regression analyses. Decreased adjusted odds ratio were determined in the case of public university students (aOR: 0.35; 95% CI: 0.19–0.63). Increased adjusted odds ratio was calculated for the Science and Engineering (aOR: 4.26; 95% CI: 2.46–7.49) and Medical Studies (aOR: 12.79; 95% CI: 4.40–47.08) students. Univariate analyses also determined the university type and degree major as significant predictors of attitude level. Public university students (OR: 0.64; 95% CI: 0.42–0.96) reported decreased odds of having a positive attitude. Students from Security and Strategic Studies reported decreased odds of having a positive attitude (OR: 0.32; 95% CI: 0.16–0.61). In contrast, Medical Studies students demonstrated increased odds of having a positive attitude (OR: 2.75; 95% CI: 1.27–6.47). Multiple analyses determined only the degree major as a significant predictor of attitude level. Decreased adjusted odds of having a positive attitude were found for the Security and Strategic Studies students (aOR: 0.32; 95% CI: 0.17–0.62).
Table 6

Predictors of knowledge and attitude towards COVID-19 vaccine (n = 449).

PredictorsKnowledgeAttitude
ORc (95% CI)aORd (95% CI)ORc (95% CI)aORd (95% CI)
1. Gender
• Female11
• Male1.00 (0.69–1.46)0.91 (0.62–1.34)
2. Marital status
• Married11
• Unmarried0.45 (0.19–1.01)1.36 (0.63–2.83)
3. Living with family
• No11
• Yes1.67 (0.89–3.18)1.10 (0.56–2.09)
4. Current accommodation
• Dhaka city11
• Outside Dhaka city0.95 (0.62–1.46)1.18 (0.76–1.85)
5. University type
• Private11
• Public0.19 (0.12–0.30) ***0.35 (0.19–0.63) ***0.64 (0.42–0.96) *
6. University year
• 1st and 2nd year11
• 3rd year1.57 (0.99–2.49)1.07 (0.67–1.72)
• 4th year and Masters1.46 (0.89–2.43)1.29 (0.76–2.18)
7. Degree Major
• Arts and Social Science11
• Business and Economics2.39 (1.31–4.41) **1.28 (0.62–2.61)0.58 (0.32–1.07)0.53 (0.27–1.06)
• Science and Engineering5.69 (3.36–9.81) ***4.26 (2.46–7.49) ***1.01 (0.60–1.71)0.97 (0.56–1.68)
• Security and Strategic Studies1.05 (0.54–2.03)1.13 (0.57–2.18)0.32 (0.16–0.61) ***0.32 (0.17–0.62) ***
• Medical Studies27.80 (1052–96.45) ***12.79 (4.40–47.08) ***2.75 (1.27–6.47) *2.45 (1.01–6.35)
8. COVID-19 positive before
• No11
• Yes1.29(0.81–2.06)0.95(0.60–1.53)

*p<0.05

**p<0.01

***p<0.001.

cOR = Odds Ratio.

daOR = Adjusted Odds Ratio.

*p<0.05 **p<0.01 ***p<0.001. cOR = Odds Ratio. daOR = Adjusted Odds Ratio. Univariate analyses determined the university type, university year, and degree major as significant predictors of hesitancy (Table 7). Increased odds of having hesitancy were found in public university students (OR: 4.62; 95% CI: 2.70–8.31) compared to the private university students. Decreased odds of having hesitancy were calculated when compared the 3rd year students (OR: 0.53; 95% CI: 0.32–0.88) with 1st and 2nd year students; compared the students major in Business and Economics (OR: 0.18; 95% CI: 0.08–0.38), Science and Engineering (OR: 0.29; 95% CI: 0.17–0.50), Security and Strategic Studies (OR: 0.42; 95% CI: 0.21–0.82) and Medical Studies (OR: 0.06; 95% CI: 0.01–0.16) with Arts and Social Science major students. All the significant predictors, except the university year, determined in univariate analyses remained significant in multiple analyses. Increased adjusted odds ratios were recorded for public university students (aOR: 2.29; 95% CI: 1.19–4.55). Conversely, decreased adjusted odds ratio were found in case of the students from Business and Economics (aOR: 0.30; 95% CI: 0.12–0.67), Science and Engineering (aOR: 0.37; 95% CI: 0.20–0.68), Security and Strategic Studies (aOR: 0.43; 95% CI: 0.21–0.84) and Medical Studies (aOR: 0.10; 95% CI: 0.02–0.35).
Table 7

Predictors of hesitancy towards COVID-19 vaccine (n = 449).

PredictorsHesitancy
ORc (95% CI)aORd (95% CI)
1. Gender
• Female1
• Male1.02 (0.67–1.56)
2. Marital status
• Married1
• Unmarried2.50 (0.95–8.60)
3. Living with family
• No1
• Yes1.18 (0.58–2.60)
4. Current accommodation
• Dhaka city1
• Outside Dhaka city0.81 (0.49–1.31)
5. University type
• Private1
• Public4.62 (2.70–8.31) ***2.29 (1.19–4.55) *
6. University year
• 1st and 2nd year1
• 3rd year0.53 (0.32–0.88) *
• 4th year and Masters0.67 (0.38–1.15)
7. Degree Major
• Arts and Social Science1
• Business and Economics0.18 (0.08–0.38) ***0.30 (0.12–0.67) **
• Science and Engineering0.29 (0.17–0.50) ***0.37 (0.20–0.68) **
• Security and Strategic Studies0.42 (0.21–0.82) *0.43 (0.21–0.84) *
• Medical Studies0.06 (0.01–0.16) ***0.10 (0.02–0.35) ***
8. COVID-19 positive before
• No1
• Yes0.58 (0.32–1.00)

*p<0.05

**p<0.01

***p<0.001.

cOR = Odds Ratio.

daOR = Adjusted Odds Ratio.

*p<0.05 **p<0.01 ***p<0.001. cOR = Odds Ratio. daOR = Adjusted Odds Ratio. Overall, 26.06% (n = 117) of the participants showed their hesitancy towards the COVID-19 vaccine. Table 8 shows that the fear of side effects (87.18) and lack of information (70.94%) were recorded as major reasons for the hesitancy. aCI = Confidence Intervals.

Discussion

University students in Bangladesh have already been greatly affected due to the COVID-19 [28, 44, 45]. It is vital to include university students in the COVID-19 vaccination program. However, no research has been done on their responses to the new COVID-19 vaccination. This study, we believe, is the first to assess their KAH regarding the vaccine. This study indicates that students understand the need to maintain healthy habits (mask, handwashing, and avoiding crowds) even after the 1st dose of vaccine. However, many of these students did not believe the available COVID-19 vaccines, and most were worried about the pandemic. Other research revealed the pandemic’s impact on academics and mental health [28]. We found that positive knowledge and attitude may reflect vaccination hesitancy among university students. But many of these students had negative knowledge and attitudes. The authority should boost vaccination knowledge before the inoculation campaign, especially for university students [30]. This study indicated that many students were unaware of vaccination myths. Misconceptions about the safety and efficacy of the vaccine could also delay inoculation campaigns [12]. Media has always been an essential factor in enhancing perception, which was also found during COVID-19 [46]. Our study identified that the internet, social media, and electronic media (TV, Radio) played a major role in reaching university students. It also supports another study [47] which found that most public university students had COVID-19 relevant information from electronic media followed by social media and the internet. These modern media can play a vital role in disseminating authentic COVID-19 vaccine information. Web-based and mobile applications can also be positive media for this purpose. The study already indicated the increasing popularity of the internet and social media in developing countries [48]. Social media has already contributed [49] substantially during the pandemic where social distancing was the primary concern. Socio-demographic and academic information is essential to track university students. Thus, evaluating the association between this information and the KAH domain level becomes crucial. Our study found that only academic information is the predictor of knowledge, attitude, and hesitancy towards the COVID-19 vaccine. Several studies on COVID-19 vaccine hesitancy among Bangladeshi respondents evaluated socio-demographic information, behavioral predictors, and academic information [18-20]. One study conducted among Czech university students found socio-demographic information such as gender and nationality as significant predictors of COVID-19 vaccine hesitancy [16]. They also found that knowledge level and dependent media as significant predictors of vaccine hesitancy. Another study conducted among Italian university students also found gender, major, and lower academic level as significant predictors of vaccine hesitancy [50]. University rank was also found as significant predictor of vaccine hesitancy among university students of Lebanon [17]. Our study found that the public university students reported negative knowledge and attitude compared to private university students. They also showed hesitancy towards the vaccine. In Bangladesh, public university students are among the most affected student groups during the pandemic [47]. They have been suffering due to the long-term closure period of the university. A large number of economically deprived students with poor internet networks placed many public universities in challenging situations. They faced challenges to start online academic activities where most private universities have already started it [28, 51]. Even with several challenges [52], online academic activities might improve the perception level among private university students. Bangladesh’s government has already taken initiatives to ensure online educational activities in all universities [53]. Medical Studies students showed positive knowledge, positive attitude, and thereby low hesitancy. These students might have better access to authentic COVID-19 vaccine-related information compared to other majoring students. They play a critical role in the vaccination campaign by disseminating reliable information regarding the effectiveness and safety of COVID-19 vaccines [54, 55]. Their health-related knowledge and attitudes are at the pinnacle of the student body, making them the go-to people for advice on public health concerns [55, 56]. However, they may have drivers of vaccine hesitancy, such as side effects of new vaccines and available vaccines in the local health center [55]. This study revealed some responsible factors for the hesitancy regarding the COVID-19 vaccine, which can be addressed as followings: Fear of side effects and a lack of information were identified as the top two reasons for hesitancy about the COVID-19 vaccine. The government and appropriate authorities should examine various measures to address these issues. A holistic strategy should be taken, in which individuals from all sectors, including university administration, collaborate to vaccinate a significant number of university students. Collaboration between researchers, universities, the government, and other relevant entities should be taken into account. Researchers might give information on the vaccination status, challenges, and strategic solutions, assisting the government and university authorities in implementing a successful vaccination program. Numerous studies have been done to establish the COVID-19 vaccine’s safety on an independent basis, with the objective of lowering public vaccination hesitancy [57, 58]. Responsible authorities may consider using a variety of communication platforms, including the internet, social media, and electronic media, to distribute accurate information about the COVID-19 vaccine. They may also utilize mobile apps to reach university students who are avid users of various mobile applications. The university administration should treat pandemic as a serious concern. Their students should be knowledgeable about it. They are capable of incorporating pandemic-related studies into any type of major. They have the option of revising the present curriculum. Additionally, the government can aid in this endeavor. Finally, our findings underscore the critical nature of the COVID-19 awareness campaign in order to ensure a timely and successful vaccination program. Sufficient accurate information regarding the vaccination can boost confidence. Like other studies, this study has some limitations. Due to the ongoing pandemic, we considered a self-reported online survey that might not reach respondents without internet access. This study required a rapid survey to examine the responses during the mass administration of the COVID-19 vaccine in Bangladesh. It was also conducted before the inoculation campaign for university students. The perception level and hesitancy might change over time, where Bangladesh authorities have already been considering several available COVID-19 vaccines [59]. However, this exploratory study provides essential information for making the inoculation campaign effective. Further research should be conducted to evaluate the perception and hesitancy level over time.

Conclusion

This study provides useful information for the successful inoculation campaign among university students. The success of the inoculation campaign largely depends on the hesitancy towards the vaccine. The low hesitancy can be possible by disseminating enough authentic information among these students. Since the university students mostly used the internet, social media, and electronic media for COVID-19 vaccine-related information, extensive campaigns through these media should be incorporated along with the inoculation campaign. Collaborations between the university and authority are also required. Furthermore, the university should revise the existing curriculum to ensure the pandemic relevant subject and activities. It can also prepare the whole community for the future pandemic since university students can act as a hub to reach their surrounding communities. (DOCX) Click here for additional data file. 28 May 2021 Submitted filename: Rebuttal letter.docx Click here for additional data file. 6 Dec 2021
PONE-D-21-17512
Knowledge, attitude, and hesitation towards covid-19 vaccine among university students of Bangladesh
PLOS ONE Dear Dr. Rahman, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
Three reviewers have evaluated your submission and have identified a range of points that need to be addressed in relation to the description of the study designs and the presentation of your manuscript. Please respond carefully to all of the reviewers concerns when preparing your revisions. Please submit your revised manuscript by Jan 08 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Jamie Males Staff Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3. Thank you for stating the following financial disclosure: "They was no external fund for this research." At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear author(s), Thank you for your esteemed efforts that aimed to increase our collective knowledge about the ongoing situation COVID-19 vaccine hesitancy among young adults population. Please consider the following minor comments: 1. Add operational (working definitions) for electronic media, social media resources, etc. 2. Use CHERRIS guidelines in structring and reporting your study and cite it your Methods section. Ref: https://pubmed.ncbi.nlm.nih.gov/15471760 4. It is not clear nor validated how the question about "relevant subject to vaccine" can be used in this situation. Of course, the level of knowledge that a medical students in terms of infectious diseases and immunization is not comprable to the level of knowledge that a student in humantrian sciences will get. I would suggest you to omit this question from your manuscript and your analysis. 5. In Table 2, please correct (06) and (04). Remove the zero. 6. In Table 3, please add a dash in the coloumn of CI instead of the word "to". 7. In Line 169, you mentioned for the first time in the manuscript that a small fraction of your sample was already vaccinated. As long this small fraction is not useful for downstream analysis, I would strongly recommend you to remove them from the begining and exclude them because their inclusion will overestimate the results. 8. Line 271 - 281: you can compare your results to other results from different countries university students. Ref: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470400 9. Line 282: you can mention the role of medical students as well within the context of public campaigns for vaccines and their particular drivers of vaccines hesitancy during COVID-19. Ref: https://pubmed.ncbi.nlm.nih.gov/34072500 10. Line 292, you can mention the COVID-19 vaccine safety studies that aim to provide independent evidence on the COVID-19 vaccine safety that can suppress the public levels of vaccine hesitancy. Ref: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345554 Ref: https://pubmed.ncbi.nlm.nih.gov/34577573 Sincerely, Reviewer #2: This manuscript is noteworthy in the current era of COVID-19 pandemic because the issue of vaccine hesitancy is extremely important as WHO considers vaccine hesitancy as a significant threat to global health. The COVID-19 vaccine is one of the top priorities in the battle against the pandemic, but its effectiveness is dependent on individual decisions since vaccines are voluntary. Apart from scarcity in dose availability and inequity in vaccine delivery, vaccine hesitancy is one of the most serious challenges in this regard. A main finding of the study, that there is still a considerable vaccine hesitancy among university students despite their goog knowledge and positive attitude, which is consistent with studies in other countries and across broad demographic groups. However, some issues needed to be addressed first to improve the quality of the manuscript: though, the following are general outlines of the required modifications: Title: It is better to replace "hesitation" with "hesitancy" also along the whole manuscript. - Language editing is needed for multiple issues - Introduction: - It would be good to provide a background on COVID-specific reasons for vaccine hesitancy, along with the general ones. - Some background on vaccination plans in the Bangladesh should be displayed such as What vaccines are being considered, is the vaccination program already planned, number of currently vaccinated person. What is the perception of vaccines in Bangladesh, e.g., in the news? These are all crucial factors playing a role in vaccine hesitancy and affecting its dynamics. - The rationale, study hypothesis and the study questions should be clearly stated Methodology section: issues in the study design and settings. Methods: - " The current survey was performed among university students" - Each group should be defined; by mentioning the study plan of each faculty and whether their curriculum contain COVI-19 vaccination topics or not? - Also sample size calculation and sampling technique (details of methods of selection of participants) are not mentioned in the manuscript. - - Results: - What is the age of the participants? Knowledge leveling is either Good or poor or adequate & inadequate NOT positive or negative as the attitude What is the level of COVID-19 vaccination hesitancy? Where this percentage in the results?? It needs a separate table as knowledge and attitude as it is one if the study objectives - Discussion: - Generally, the discussion is somewhat redundant without adequate structure and should be focused to compare the results with similar studies and to explain and give the implications of the study results. - Please make the discussion more concise, without discussing too many details but the most important results and their general meaning. - Having some bullet points on how to address the observed hesitancy would be beneficial for the discussion and the entire manuscript. - References: - Needs revision as sometimes they are not consistent in their style. Some of them are incomplete Reviewer #3: This is a well-written manuscript that evaluates hesitancy towards the COVID-19 vaccine in University students in Bangladesh. The results are consistent with several other studies in other locations, if not entirely novel. My minor concern is that the university student population may be very different from the population at large. Although this is clearly a manuscript about university students, some effort to compare the university population to the population of Bangladesh as a whole would be appreciated. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. Submitted filename: PONE-D-21-17512. report.docx Click here for additional data file. 25 Feb 2022 Reviewer #1: Dear author(s), Thank you for your esteemed efforts that aimed to increase our collective knowledge about the ongoing situation COVID-19 vaccine hesitancy among young adults population. Please consider the following minor comments: 1. Add operational (working definitions) for electronic media, social media resources, etc. Response: Thank you for the comment. We have added operational definitions for the internet, electronic media, and social media after Table 2 in Results section. 2. Use CHERRIS guidelines in structring and reporting your study and cite it your Methods section. Ref: https://pubmed.ncbi.nlm.nih.gov/15471760 Response: Thank you for the suggestion. We have revised our Methods following CHERRIS guidelines. We have also cited it in our Methods section. 4. It is not clear nor validated how the question about "relevant subject to vaccine" can be used in this situation. Of course, the level of knowledge that a medical students in terms of infectious diseases and immunization is not comprable to the level of knowledge that a student in humantrian sciences will get. I would suggest you to omit this question from your manuscript and your analysis. Response: Thank you for pointing out it. We have omitted that question from our manuscript and our analysis. 5. In Table 2, please correct (06) and (04). Remove the zero. Response: Thank you. We have corrected those numbers. 6. In Table 3, please add a dash in the coloumn of CI instead of the word "to". Response: Thank you. We have replaced the word “to” by dash in the column of CI for all Table (including Table 3) to maintain the consistency. 7. In Line 169, you mentioned for the first time in the manuscript that a small fraction of your sample was already vaccinated. As long this small fraction is not useful for downstream analysis, I would strongly recommend you to remove them from the begining and exclude them because their inclusion will overestimate the results. Response: Thank you for the recommendation. We have removed that small fraction from our sample who were vaccinated. We have mentioned it in our Methods, and revised our Results from the beginning. 8. Line 271 - 281: you can compare your results to other results from different countries university students. Ref: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470400 Response: Thank you. We have revised that part following your comment. We have also added the above reference. 9. Line 282: you can mention the role of medical students as well within the context of public campaigns for vaccines and their particular drivers of vaccines hesitancy during COVID-19. Ref: https://pubmed.ncbi.nlm.nih.gov/34072500 Response: Thank you. We have revised and cited some new references following the abovementioned reference. 10. Line 292, you can mention the COVID-19 vaccine safety studies that aim to provide independent evidence on the COVID-19 vaccine safety that can suppress the public levels of vaccine hesitancy. Ref: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345554 Ref: https://pubmed.ncbi.nlm.nih.gov/34577573 Response: Thank you very much for all effective comments and suggestions which have improved the quality of our manuscript a lot. We have revised with the abovementioned references following you and another reviewer’s comments. Reviewer #2: This manuscript is noteworthy in the current era of COVID-19 pandemic because the issue of vaccine hesitancy is extremely important as WHO considers vaccine hesitancy as a significant threat to global health. The COVID-19 vaccine is one of the top priorities in the battle against the pandemic, but its effectiveness is dependent on individual decisions since vaccines are voluntary. Apart from scarcity in dose availability and inequity in vaccine delivery, vaccine hesitancy is one of the most serious challenges in this regard. A main finding of the study, that there is still a considerable vaccine hesitancy among university students despite their goog knowledge and positive attitude, which is consistent with studies in other countries and across broad demographic groups. However, some issues needed to be addressed first to improve the quality of the manuscript: though, the following are general outlines of the required modifications: Title: It is better to replace "hesitation" with "hesitancy" also along the whole manuscript. Response: Thank you very much for appreciating our work which will encourage us to conduct further research. We have replaced "hesitation" with "hesitancy" in both title and whole manuscript. - Language editing is needed for multiple issues Response: Thank you. We have done major revision and checked the language. We hope the current version would satisfy you. -Introduction: - It would be good to provide a background on COVID-specific reasons for vaccine hesitancy, along with the general ones. Response: Thank you again. We have revised and provide background on COVID-specific reasons for vaccine hesitancy, along with general ones. - Some background on vaccination plans in the Bangladesh should be displayed such as What vaccines are being considered, is the vaccination program already planned, number of currently vaccinated person. What is the perception of vaccines in Bangladesh, e.g., in the news? These are all crucial factors playing a role in vaccine hesitancy and affecting its dynamics. Response: Thank you. We have revised and added the information following your comment. Please check the introduction part. - The rationale, study hypothesis and the study questions should be clearly stated Response: Thank you. We have revised again following your comment. We hope that the current revised version will satisfy you. Methodology section: issues in the study design and settings. Methods: - " The current survey was performed among university students" - Each group should be defined; by mentioning the study plan of each faculty and whether their curriculum contain COVI-19 vaccination topics or not? Response: Thank you for pointing out it. Actually, we have divided 5 groups based on the major considering Bangladesh perspective. We wanted to examine if there were any differences among these groups. All these groups have diverse study plan and curriculum. For instance, Science and Engineering includes several study plans based on the university authority. However, we have revised our Research design following your comment. We discussed the differences among these groups based on our hypothesis in Methods and Discussion section. We have also deleted “COVID-19 relevant subject” from our manuscript following another reviewer’s suggestion. - Also sample size calculation and sampling technique (details of methods of selection of participants) are not mentioned in the manuscript. Response: Thank you. We have revised and put the information regarding sampling technique in Data collection and data analysis section as “We followed the convenience sampling technique. Convenience sampling is a technique for non-probabilistic sampling that is frequently used in clinical research. Typically, this sampling strategy draws clinical cases or participants from an easily accessible area, such as a medical records database, an internet site, or a customer membership list [39].” For sample size, we followed Morgan’s Table which determined the minimum required respondents were 384 for this perception-based study (95% Confidence Interval (CI)). We have also mentioned it in Data collection and data analysis section. -Results: - What is the age of the participants? Response: Thank you. The age of this young adult was 18-25 years. Since, majority of them were in same age group, we did not consider in our analysis. Knowledge leveling is either Good or poor or adequate & inadequate NOT positive or negative as the attitude What is the level of COVID-19 vaccination hesitancy? Where this percentage in the results?? It needs a separate table as knowledge and attitude as it is one if the study objectives. Response: Thank you again. We have mentioned that overall, 26.06% of the participants showed their positive hesitancy towards the COVID-19 vaccine. Hesitancy was measured based on their positive and negative response, and then the factors responsible for this hesitancy. Table 7 and Table 8 summarizes the result regarding hesitancy towards the COVID-19 vaccine. Table 8 also shows the percentages. -Discussion: - Generally, the discussion is somewhat redundant without adequate structure and should be focused to compare the results with similar studies and to explain and give the implications of the study results. Response: Thank you. We have revised and added some other similar studies following you and other reviewers’ comments. - Please make the discussion more concise, without discussing too many details but the most important results and their general meaning. Response: Thank you. We have revised the discussion part following your comment. We may still have some discussion to clarify the understanding following other relevant studies. - Having some bullet points on how to address the observed hesitancy would be beneficial for the discussion and the entire manuscript. Response: Thank you. We have revised and provided some bullet points before limitation of the research. -References: - Needs revision as sometimes they are not consistent in their style. Some of them are incomplete Response: Thank you. We have revised again. We actually used referencing management tool. Reviewer #3: This is a well-written manuscript that evaluates hesitancy towards the COVID-19 vaccine in University students in Bangladesh. The results are consistent with several other studies in other locations, if not entirely novel. My minor concern is that the university student population may be very different from the population at large. Although this is clearly a manuscript about university students, some effort to compare the university population to the population of Bangladesh as a whole would be appreciated. Response: Thank you very much. We have done major revision following all reviewers’ comments and suggestions which also included COVID-19 vaccine information regarding general population of Bangladesh (please check both introduction and discussion part). We also have added some references which considered general population of Bangladesh. Submitted filename: Response to Reviewers.docx Click here for additional data file. 16 Jun 2022 Knowledge, attitude, and hesitancy towards COVID-19 vaccine among university students of Bangladesh PONE-D-21-17512R1 Dear Dr. Rahman, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Jianhong Zhou Staff Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear Author(s), Thank you for your esteemed efforts in responding to all my previous points. I do believe that the manuscript is in good shape now for being accepted. Good luck! Sincerely, Reviewer #2: Thanks for doing the modifications... The manuscript now is suitable to be published as most of the corrections were done as needed ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No 17 Jun 2022 PONE-D-21-17512R1 Knowledge, attitude, and hesitancy towards COVID-19 vaccine among university students of Bangladesh Dear Dr. Rahman: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Jianhong Zhou Staff Editor PLOS ONE
  29 in total

1.  Vaccine hesitancy among healthcare workers in Europe: A qualitative study.

Authors:  Emilie Karafillakis; Irina Dinca; Franklin Apfel; Sabrina Cecconi; Andrea Wűrz; Judit Takacs; Jonathan Suk; Lucia Pastore Celentano; Piotr Kramarz; Heidi J Larson
Journal:  Vaccine       Date:  2016-08-26       Impact factor: 3.641

2.  Population Research: Convenience Sampling Strategies.

Authors:  Samuel J Stratton
Journal:  Prehosp Disaster Med       Date:  2021-08       Impact factor: 2.040

3.  Psychological responses during the COVID-19 outbreak among university students in Bangladesh.

Authors:  Md Saiful Islam; Md Safaet Hossain Sujan; Rafia Tasnim; Md Tajuddin Sikder; Marc N Potenza; Jim van Os
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

4.  COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side Effects.

Authors:  Abanoub Riad; Holger Schünemann; Sameh Attia; Tina Poklepović Peričić; Marija Franka Žuljević; Mikk Jürisson; Ruth Kalda; Katrin Lang; Sudhakar Morankar; Elias Ali Yesuf; Mohamed Mekhemar; Anthony Danso-Appiah; Ahmad Sofi-Mahmudi; Giordano Pérez-Gaxiola; Arkadiusz Dziedzic; João Apóstolo; Daniela Cardoso; Janja Marc; Mayte Moreno-Casbas; Charles Shey Wiysonge; Amir Qaseem; Anna Gryschek; Ivana Tadić; Salman Hussain; Mohammed Ahmed Khan; Jitka Klugarova; Andrea Pokorna; Michal Koščík; Miloslav Klugar
Journal:  Int J Environ Res Public Health       Date:  2021-07-25       Impact factor: 3.390

5.  Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES).

Authors:  Gunther Eysenbach
Journal:  J Med Internet Res       Date:  2004-09-29       Impact factor: 5.428

6.  Social Media in the Times of COVID-19.

Authors:  Ashish Goel; Latika Gupta
Journal:  J Clin Rheumatol       Date:  2020-09       Impact factor: 3.517

7.  Depression and anxiety among university students during the COVID-19 pandemic in Bangladesh: A web-based cross-sectional survey.

Authors:  Md Akhtarul Islam; Sutapa Dey Barna; Hasin Raihan; Md Nafiul Alam Khan; Md Tanvir Hossain
Journal:  PLoS One       Date:  2020-08-26       Impact factor: 3.240

View more
  2 in total

1.  Mental Health Condition among University Students of Bangladesh during the Critical COVID-19 Period.

Authors:  Md Mostafizur Rahman; Saadmaan Jubayer Khan; Anuva Arony; Zahid Al Mamun; Nawwar Fatima Procheta; Mohammed Sadman Sakib; Komal Raj Aryal; Farzana Rahman; Abu Reza Md Towfiqul Islam
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

2.  Satisfaction with COVID-19 Vaccines in Health Care Workers and the General Population: A Cross-Sectional Study in Urban Bangkok, Thailand.

Authors:  Jadsada Kunno; Pataraporn Yubonpunt; Chavanant Sumanasrethakul; Chuthamat Kaewchandee; Mark Gregory Robson; Wachiraporn Wanichnopparat; Krit Prasittichok; Titaporn Luangwilai; Chonlawat Chaichan; Patcharaporn Krainara; Busaba Supawattanabodee
Journal:  Vaccines (Basel)       Date:  2022-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.